Quickscreen Pro Multi Drug Screening Test, Model 9153 PAT04
by Phamatech 510(k)
Active
510(k) K000131
Overview
The Quickscreen Pro Multi Drug Screening Test, Model 9153 PAT04, is an enzyme immunoassay device used for the detection of cannabinoids. It functions as a screening test to identify the presence of specific substances within clinical toxicology applications.
This device is manufactured by Phamatech and has received FDA 510(k) clearance. It is classified as a Class II device under regulation number 862.3870.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK000131 | Date4 Feb 2000 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- LDJ
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3870
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Other devices from Phamatech Inc.
Questions
What is the primary purpose of the Quickscreen Pro Model 9153 PAT04?
This device is an enzyme immunoassay used for the detection of cannabinoids. It is designed to function as a screening test to identify the presence of these specific substances within clinical toxicology applications.
What is the regulatory classification of this screening test?
The Quickscreen Pro Model 9153 PAT04 is classified as a Class II device under regulation number 862.3870. It has received FDA 510(k) clearance for its intended use in clinical toxicology.
Who is the manufacturer of this device?
The device is manufactured by Phamatech, located in San Diego, California. The company is the applicant responsible for the FDA 510(k) clearance associated with this specific model.